205 related articles for article (PubMed ID: 37606350)
21. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.
Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J
Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
Luo J; Zhu X; Jian J; Chen X; Yin K
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
[TBL] [Abstract][Full Text] [Related]
23. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.
Bavishi C; Bonow RO; Trivedi V; Abbott JD; Messerli FH; Bhatt DL
Prog Cardiovasc Dis; 2020; 63(5):682-689. PubMed ID: 32512122
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular disorders in patients infected with 2019 novel coronavirus].
Aidan V; Davido B; Mustafic H; Dinh A; Mansencal N; Fayssoil A
Ann Cardiol Angeiol (Paris); 2021 Apr; 70(2):106-115. PubMed ID: 33642045
[TBL] [Abstract][Full Text] [Related]
25. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB
Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670
[No Abstract] [Full Text] [Related]
26. COVID and Cardiovascular Disease: What We Know in 2021.
Chilazi M; Duffy EY; Thakkar A; Michos ED
Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
[TBL] [Abstract][Full Text] [Related]
27. Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19.
Tuo H; Li W; Tang L; He B; Yao B; Mao P; Tang Q
Int Heart J; 2021; 62(1):148-152. PubMed ID: 33518653
[TBL] [Abstract][Full Text] [Related]
28. Renal manifestations, incidence, pathogenesis and implications on prognosis and mortality in COVID-19 patients: A review of current evidence and the potential for future directions.
Haq K; Mahmood F; Ghaly M
Clin Nephrol; 2021 Aug; 96(2):67-81. PubMed ID: 34142945
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and cardiovascular disease in patients with chronic kidney disease.
Del Vecchio L; Balafa O; Dounousi E; Ekart R; Fernandez BF; Mark PB; Sarafidis P; Valdivielso JM; Ferro CJ; Mallamaci F
Nephrol Dial Transplant; 2024 Jan; 39(2):177-189. PubMed ID: 37771078
[TBL] [Abstract][Full Text] [Related]
30. [Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].
Kamel S; Raynor A; Zozor S; Lacape G; Brunel V; Nivet-Antoine V; Collin-Chavagnac D; Peoc'h K; Cohen A; Lassoued AB; Chévrier M; Alemann M; Lessinger JM; Bérard AM; Sapin V; Beauvieux MC; Levy P;
Ann Biol Clin (Paris); 2021 Jun; 79(3):219-231. PubMed ID: 34165431
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.
Aboughdir M; Kirwin T; Abdul Khader A; Wang B
Viruses; 2020 May; 12(5):. PubMed ID: 32403242
[TBL] [Abstract][Full Text] [Related]
32. Post-acute COVID-19 syndrome.
Nalbandian A; Sehgal K; Gupta A; Madhavan MV; McGroder C; Stevens JS; Cook JR; Nordvig AS; Shalev D; Sehrawat TS; Ahluwalia N; Bikdeli B; Dietz D; Der-Nigoghossian C; Liyanage-Don N; Rosner GF; Bernstein EJ; Mohan S; Beckley AA; Seres DS; Choueiri TK; Uriel N; Ausiello JC; Accili D; Freedberg DE; Baldwin M; Schwartz A; Brodie D; Garcia CK; Elkind MSV; Connors JM; Bilezikian JP; Landry DW; Wan EY
Nat Med; 2021 Apr; 27(4):601-615. PubMed ID: 33753937
[TBL] [Abstract][Full Text] [Related]
33. Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment.
Khalid M; Awan S; Jatoi NN; Jatoi HN; Yasmin F; Ochani RK; Batra S; Malik F; Ahmed J; Chawla S; Mustafa A; Lak HM; Surani S
Pan Afr Med J; 2021; 39():173. PubMed ID: 34584599
[TBL] [Abstract][Full Text] [Related]
34. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic.
Ganatra S; Dani SS; Shah S; Asnani A; Neilan TG; Lenihan D; Ky B; Barac A; Hayek SS; Leja M; Herrmann J; Thavendiranathan P; Fradley M; Bang V; Shreyder K; Parikh R; Patel R; Singh A; Brar S; Guha A; Gupta D; Mascari P; Patten RD; Venesy DM; Nohria A; Resnic FS
Trends Cardiovasc Med; 2020 Aug; 30(6):315-325. PubMed ID: 32474135
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: an update and cardiac involvement.
Alwaqfi NR; Ibrahim KS
J Cardiothorac Surg; 2020 Sep; 15(1):239. PubMed ID: 32907637
[TBL] [Abstract][Full Text] [Related]
36. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.
Zaman S; MacIsaac AI; Jennings GL; Schlaich MP; Inglis SC; Arnold R; Kumar S; Thomas L; Wahi S; Lo S; Naismith C; Duffy SJ; Nicholls SJ; Newcomb A; Almeida AA; Wong S; Lund M; Chew DP; Kritharides L; Chow CK; Bhindi R
Med J Aust; 2020 Aug; 213(4):182-187. PubMed ID: 32734645
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.
Dhakal BP; Sweitzer NK; Indik JH; Acharya D; William P
Heart Lung Circ; 2020 Jul; 29(7):973-987. PubMed ID: 32601020
[TBL] [Abstract][Full Text] [Related]
39. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
[TBL] [Abstract][Full Text] [Related]
40. The Cardiovascular Manifestations of COVID-19.
Louis DW; Saad M; Vijayakumar S; Ilyas S; Kokkirala A; Aronow HD
Heart Fail Clin; 2023 Apr; 19(2):153-161. PubMed ID: 36863807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
